Efficacy and safety of venetoclax-based regimens for the treatment of relapsed/refractory multiple myeloma: a systemic review and meta-analysis.

Ther Adv Hematol · 2023 · PMC9989383 · PMID 36895915

Europe PMC DOI

hedged sentence

0.0890

closest p · 1.8× alpha

0.0890

boldest claim

The sentences

did not reach statistical significancep = 0.089so close (0.05 < p ≤ 0.1)

There was a tendency of increased rate of ≧VGPR among patients with more drugs combined, but this did not reach statistical significance ( p = 0.089).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.